title: Author's reply.
authors.affiliation: Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany.
authors.forename: Jörg
authors.initials: J
authors.lastname: Stypmann
authors.affiliation: Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany.
authors.forename: Markus
authors.initials: M
authors.lastname: Engelen
authors.affiliation: Center for Laboratory Medicine, University Hospital Münster, Münster, Germany. Electronic address: nofer@uni-muenster.de.
authors.forename: Jerzy-Roch
authors.initials: JR
authors.lastname: Nofer
mesh_terms: D000209:Acute-Phase Proteins / Q000032:analysis*; D000068338:Everolimus / Q000627:therapeutic use*; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects*; D054834:Lipocalins / Q000032:analysis*; D008297:Male; D011518:Proto-Oncogene Proteins / Q000032:analysis*
chemical_list: D000209:Acute-Phase Proteins; D007166:Immunosuppressive Agents; D054834:Lipocalins; D011518:Proto-Oncogene Proteins; D000068338:Everolimus